Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure (NCT06423664)
Pilot Feasibility Trial of Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure (INTACT)
๐ฉบ Plain-English Summary (8th-Grade Level)
The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.
Who can join: Review the eligibility criteria below.
Location: University of New Mexico Health Sciences Center โ Albuquerque, New Mexico
Age range: Not specified to 7 Days
๐งช Interventions in This Study
- Play and Learn Strategies (PALS) Program (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (3 Sites)
- University of New Mexico Health Sciences Center โ Albuquerque, New Mexico
- Avera Research Institute โ Sioux Falls, South Dakota
- University of Vermont Medical Center โ Burlington, Vermont
๐ Contact the Study Coordinator
Phone: (501) 686-5647
Email: STOunpraseuth@uams.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Developmental Delay
- School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays โ Chicago, Illinois
- Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder โ Bethesda, Maryland
Explore by condition: All Developmental Delay clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.